EKF DIAGNOSTICS INC

EKF DIAGNOSTICS INC specializes in the design, manufacturing, and quality-assured production of in vitro diagnostic instruments and reagents for clinical laboratories. The company’s technical expertise lies in electrochemical sensing, immunoassay platforms, and point-of-care diagnostic systems, with a focus on precision analyzers for blood testing, glucose monitoring, and infectious disease detection. Their core capabilities include regulatory-compliant device development, ISO 13485-aligned manufacturing processes, and calibration systems meeting CLIA and CE-IVDR standards. Differentiators include proprietary sensor technology, miniaturized lab-on-a-chip designs, and closed-system instrumentation that minimizes operator error and enhances reproducibility in high-volume clinical environments. No award history is available to infer specific agency engagements or contracting patterns. Consequently, no direct relationship with federal agencies can be confirmed from the provided data. The company operates within the medical device manufacturing sector, primarily under NAICS 325412, which encompasses the production of diagnostic reagents and laboratory equipment. Their market positioning centers on high-reliability diagnostic hardware for clinical and hospital settings, with an emphasis on automation, sample throughput, and regulatory compliance. While no public certifications are listed, their operations align with FDA 21 CFR Part 820 and international medical device quality standards. EKF DIAGNOSTICS INC is structured as a small business (2L entity) headquartered in Boerne, Texas, with no government-recognized certifications on record. The company’s geographic presence is concentrated in Texas, and its government market positioning remains undefined due to the absence of publicly documented federal contracts. Its capabilities are oriented toward commercial and healthcare provider markets rather than federal procurement channels.